We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.06B
AUM Growth
-$221M
Cap. Flow
-$22.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17

Top Buys

Rank Stock Value
1
AIR icon
AAR Corp
AIR
+$23.4M
2
RDNT icon
RadNet
RDNT
+$13.8M
3
IMGN
Immunogen Inc
IMGN
+$13.8M
4
CBAY
Cymabay Therapeutics
CBAY
+$13M
5
SVV icon
Savers
SVV
+$12.6M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$32.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$27.5M
3
PLNT icon
Planet Fitness
PLNT
+$27.5M
4
SMCI icon
Super Micro Computer
SMCI
+$17.1M
5
WOOF icon
Petco
WOOF
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.32%
2 Industrials 21.96%
3 Technology 19.12%
4 Consumer Discretionary 9.24%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JACK icon
51
Jack in the Box
JACK
$286M
$16.9M 0.82%
244,812
+1
+0% +$85
FORM icon
52
FormFactor
FORM
$8.23B
$16.8M 0.82%
481,911
+177,448
+58% +$5.97M
CRDO icon
53
Credo Technology Group
CRDO
$37.8B
$16.8M 0.81%
1,103,284
-100,500
-8% -$1.59M
SVV icon
54
Savers
SVV
$1.53B
$16.3M 0.79%
870,677
+543,783
+166% +$12.6M
RPD icon
55
Rapid7
RPD
$815M
$16.1M 0.78%
350,921
-349
-0.1% -$16.1K
COLL icon
56
Collegium Pharmaceutical
COLL
$1.17B
$15.4M 0.75%
690,487
-114,303
-14% -$2.61M
AMLX icon
57
Amylyx Pharmaceuticals
AMLX
$1.97B
$15.4M 0.74%
838,572
+6,764
+0.8% +$143K
CHUY
58
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$15.1M 0.73%
423,573
+2
+0% +$77
MODN
59
DELISTED
MODEL N, INC.
MODN
$15M 0.73%
615,374
-206,596
-25% -$6.13M
CCOI icon
60
Cogent Communications
CCOI
$549M
$14.9M 0.72%
240,111
+1
+0% +$65
CBAY
61
DELISTED
Cymabay Therapeutics
CBAY
$14.7M 0.71%
+983,775
New +$13M
EVRI
62
DELISTED
Everi Holdings
EVRI
$14.6M 0.71%
1,107,989
-35,573
-3% -$506K
SNCY
63
DELISTED
Sun Country Airlines
SNCY
$14.6M 0.71%
984,407
-395
-0% -$6.97K
PPBI
64
DELISTED
Pacific Premier Bancorp
PPBI
$14.5M 0.7%
667,208
-130,908
-16% -$3.01M
VC icon
65
Visteon
VC
$2.8B
$14.4M 0.7%
104,493
-299
-0.3% -$43.1K
AMRC icon
66
Ameresco
AMRC
$1.22B
$14.2M 0.69%
369,431
+73,185
+25% +$3.54M
ICUI icon
67
ICU Medical
ICUI
$3.94B
$14M 0.68%
117,616
+1,414
+1% +$211K
BJRI icon
68
BJ's Restaurants
BJRI
$1.42B
$13.9M 0.68%
594,126
+3
+0% +$92
AGYS icon
69
Agilysys
AGYS
$3B
$13.8M 0.67%
208,388
+87,119
+72% +$6.05M
HAE icon
70
Haemonetics
HAE
$3.54B
$13.6M 0.66%
151,463
-23,387
-13% -$2.09M
EYE icon
71
National Vision
EYE
$1.66B
$13.2M 0.64%
818,204
+95,559
+13% +$1.91M
PTLO icon
72
Portillo's
PTLO
$338M
$12.9M 0.63%
841,397
+6
+0% +$117
FA icon
73
First Advantage
FA
$3.83B
$12.9M 0.62%
935,340
+248,895
+36% +$3.61M
DCGO icon
74
DocGo
DCGO
$64.3M
$12.8M 0.62%
2,406,714
+145,163
+6% +$1.18M
MTDR icon
75
Matador Resources
MTDR
$6.68B
$12.5M 0.61%
210,773
-836
-0.4% -$48.7K
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Emerald Advisers held 249 positions worth $2.06B, down 9.7% from $2.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2023 filing shows 38 new, 87 increased, 99 reduced and 17 closed positions. Its largest new stake was RadNet: 443,538 shares worth $12.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Emerald Advisers's largest Q3 2023 buy was RadNet: 443,538 shares worth $12.5M.
  • Emerald Advisers added most to AAR Corp in Q3 2023, an estimated $23.4M increase.
  • Emerald Advisers's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $17.1M.
  • Emerald Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $32.3M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.06B portfolio in Q3 2023.
  • Emerald Advisers opened 38 new positions and closed 17 in Q3 2023.
  • Emerald Advisers's portfolio value fell 9.7% quarter-over-quarter to $2.06B.

Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.